|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0012133,
umls-concept:C0015219,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0032105,
umls-concept:C0037949,
umls-concept:C0039194,
umls-concept:C0150312,
umls-concept:C0376705,
umls-concept:C0384228,
umls-concept:C1332714,
umls-concept:C1521798,
umls-concept:C2698872
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-5-17
|
|
pubmed:abstractText |
Tenofovir with full-dose didanosine has been associated with paradoxical CD4 + T cell decrease despite virological suppression. We investigated whether tenofovir plus didanosine at a weight-adjusted dosage could be responsible for such an effect, and factors associated with CD4 + T cell count evolution under this combination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0305-7453
|
|
pubmed:author |
pubmed-author:AntinoriAndreaA,
pubmed-author:AntonucciFrancescoF,
pubmed-author:BarreiroPabloP,
pubmed-author:CarosiGiampieroG,
pubmed-author:De SilvestriAnnalisaA,
pubmed-author:El HamadIssaI,
pubmed-author:Italian MASTER Cohort,
pubmed-author:LadisaNicolettaN,
pubmed-author:LapadulaGiuseppeG,
pubmed-author:MaggioloFrancoF,
pubmed-author:MandaliaSundhiyaS,
pubmed-author:MaseratiRenatoR,
pubmed-author:MigliorinoGuglielmoG,
pubmed-author:PierottiPieraP,
pubmed-author:SighinolfiLauraL,
pubmed-author:SorianoVicenteV,
pubmed-author:SuterFredyF,
pubmed-author:TortiCarloC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1141-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17434879-Adenine,
pubmed-meshheading:17434879-Adult,
pubmed-meshheading:17434879-Aging,
pubmed-meshheading:17434879-Anti-HIV Agents,
pubmed-meshheading:17434879-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:17434879-CD4 Lymphocyte Count,
pubmed-meshheading:17434879-CD4-Positive T-Lymphocytes,
pubmed-meshheading:17434879-Cohort Studies,
pubmed-meshheading:17434879-Didanosine,
pubmed-meshheading:17434879-Drug Therapy, Combination,
pubmed-meshheading:17434879-Female,
pubmed-meshheading:17434879-HIV Infections,
pubmed-meshheading:17434879-HIV-1,
pubmed-meshheading:17434879-Humans,
pubmed-meshheading:17434879-Italy,
pubmed-meshheading:17434879-Male,
pubmed-meshheading:17434879-Middle Aged,
pubmed-meshheading:17434879-Phosphonic Acids,
pubmed-meshheading:17434879-Risk Factors,
pubmed-meshheading:17434879-Sex Characteristics,
pubmed-meshheading:17434879-Treatment Outcome,
pubmed-meshheading:17434879-Viral Load
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
|
|
pubmed:affiliation |
Università degli Studi di Brescia, p le Spedali Civili 1, Brescia, Italy. torti.carlo@libero.it
|
|
pubmed:publicationType |
Journal Article
|
